Meredith Kaya | SVP, IR & Strategic Finance |
Adam Townsend | Chief Commercial Officer |
Cedric Francois | Co-Founder, President, CEO & Director |
Timothy Sullivan | CFO & Treasurer |
Federico Grossi | Chief Medical Officer |
Madhu Kumar | Goldman Sachs Group |
Umer Raffat | Evercore |
Anupam Rama | JPMorgan |
Tazeen Ahmad | Bank of America |
Lyla Youssef | Cowen |
Steven Seedhouse | Raymond James |
Colleen Kusy | RW Baird |
Derek Archila | Wells Fargo |
Justin Kim | Oppenheimer |
Yigal Nochomovitz | Citi |
Ellie Merle | UBS |
Annabel Samimy | Stifel |
Douglas Tsao | H.C. Wainwright |
Ladies and gentlemen, thank you for standing by and welcome to the Apellis Pharmaceuticals Second Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. [Operator Instructions]. I'd now like to turn the call over to your host Meredith Kaya.